COVID-19 Mutant Strain Threat Prompted Covaxin’s Approval, Say Minutes Of SEC Meetings
New Delhi: The impending danger of the new mutant strain of coronavirus found in the UK helped Bharat Biotech get emergency use approval for its vaccine candidate Covaxin. India has now reported 71 cases of mutant strain with number rising…